Ross Andrew Soo (Ross A Soo, Ross Soo)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 10

Top Topics

Irritable Bowel Syndrome

Tyrosine Kinase

Small Cell Lung Cancer

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

JCO oncology practice

Respirology (Carlton, Vic.)

This page only lists publications with an associated author ORCID identifier.

Publications

Benjamin J Solomon, Geoffrey Liu, Enriqueta Felip Font, Tony S K Mok, Ross Andrew Soo, Julien Mazieres, Alice T Shaw, Filippo de Marinis, Yasushi Goto, Yi-Long Wu, Dong Wan Kim, Jean-Francois Martini, Rossella Messina, Jolanda Paolini, Anna Polli, Despina Thomaidou, Francesca Toffalorio, Todd M Bauer
Lorlatinib Versus Crizotinib in Patients With Advanced ALK -Positive Non-Small Cell Lung Cancer: 5-Year Outcomes From the Phase III CROWN Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Ross Andrew Soo, Urania Dafni, Ji-Youn Han, Byoung Chul Cho, Ernest Nadal, Chong Ming Yeo, Enric Carcereny, Javier De Castro Carpeño, Maria Angeles Sala, Linda Coate, Mariano Provencio Pulla, Christian Britschgi, Patrick Vagenknecht, Georgia Dimopoulou, Roswitha Kammler, Stephen P Finn, Solange Peters, Rolf A Stahel
ctDNA dynamics and mechanisms of acquired resistance in patients treated with osimertinib with or without bevacizumab from the randomised phase II ETOP-BOOSTER trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Zofia Piotrowska, Daniel Shao-Weng Tan, Egbert F Smit, Alexander I Spira, Ross Andrew Soo, Danny Nguyen, Victor Ho Fun Lee, James Chih-Hsin Yang, Vamsidhar Velcheti, John M Wrangle, Mark A Socinski, Marianna Koczywas, John E Janik, Jeffrey Jones, Helena Alexandra Yu
Safety, Tolerability, and Antitumor Activity of Zipalertinib Among Patients With Non-Small-Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Exon 20 Insertions. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Chong-Kin Liam, Azura Rozila Ahmad, Te-Chun Hsia, Jian-Ying Zhou, Dong Wan Kim, Ross Andrew Soo, Ying Cheng, Shun Lu, Sang Won Shin, James Chih-Hsin Yang, Yiping Zhang, Jun Zhao, Karin Berghoff, Rolf Bruns, Andreas Johne, Yi-Long Wu
Randomized Trial of Tepotinib Plus Gefitinib Versus Chemotherapy in EGFR-Mutant NSCLC with EGFR Inhibitor Resistance Due to MET Amplification: INSIGHT Final Analysis. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Sun Min Lim, Jii Bum Lee, Yuko Oya, Jorn Nutzinger, Ross Andrew Soo
Path less Traveled: Targeting Rare Driver Oncogenes in Non-Small-Cell Lung Cancer. JCO oncology practice (2023)
Charles M Rudin, Stephen V Liu, Ross Andrew Soo, Shun Lu, Min Hee Hong, Jong-Seok Lee, Maciej Bryl, Daphne W Dumoulin, Achim Rittmeyer, Chao-Hua Chiu, Ozgur Ozyilkan, Melissa Lynne Johnson, Alejandro Navarro, Silvia Novello, Yuichi Ozawa, Sammi Hiu Tam, Namrata S Patil, Xiaohui Wen, Meilin Huang, Tien Hoang, Raymond Meng, Martin Reck
SKYSCRAPER-02: Tiragolumab in Combination With Atezolizumab Plus Chemotherapy in Untreated Extensive-Stage Small-Cell Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Byoung Chul Cho, Myung-Ju Ahn, Jin Hyoung Kang, Ross Andrew Soo, Thanyanan Reungwetwattana, James Chih-Hsin Yang, Irfan Cicin, Dong Wan Kim, Yi-Long Wu, Shun Lu, Ki Hyeong Lee, Yong-Kek Pang, Anastasia Zimina, Chin Heng Fong, Elena Poddubskaya, Ahmet Sezer, Soon Hin How, Pongwut Danchaivijitr, YuKyung Kim, Yeji Lim, Taewon An, Hana Lee, Hae Mi Byun, Bojan Zarić
Lazertinib Versus Gefitinib as First-line Treatment in Patients With EGFR -mutated Advanced Non-Small Cell Lung Cancer (NSCLC): Results From LASER301. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Joline S J Lim, Andrea L A Wong, Samuel Guan Wei Ow, Natalie Yan Li Ngoi, Gloria H J Chan, Yvonne L E Ang, Wan Qin Chong, Siew Eng Lim, Yi Wan Lim, Matilda X Lee, Joan R E Choo, Hon Lyn Tan, Wei Peng Yong, Ross Andrew Soo, David Shao Peng Tan, Cheng Ean Chee, Raghav Sundar, Kritika Yadav, Supriya Jain, Ling-Zhi Wang, Bee Choo Tai, Boon Cher Goh, Soo-Chin Lee
Phase Ib/II Dose Expansion Study of Lenvatinib Combined with Letrozole in Postmenopausal Women with Hormone Receptor-Positive Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (11) (2022)
Ross Andrew Soo, Takashi Seto, Jhanelle E Gray, Ellen Thiel, Aliki Taylor, William Sawyer, Parisa Karimi, Elizabeth Marchlewicz, Matthew Brouillette
Treatment Patterns in Patients with Locally Advanced or Metastatic Non-Small-Cell Lung Cancer Treated with Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors: Analysis of US Insurance Claims Databases. Drugs - real world outcomes (2021)
Brielle A Parris, Eloise Shaw, Brendan Pang, Richie Soong, Kwun Fong, Ross Andrew Soo
Somatic mutations and immune checkpoint biomarkers. Respirology (Carlton, Vic.) 24 (3) (2019)